nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—ABCC6—Cisplatin—esophageal cancer	0.315	0.536	CbGbCtD
Dactinomycin—ABCB1—esophageal cancer	0.292	1	CbGaD
Dactinomycin—ABCG2—Carboplatin—esophageal cancer	0.0727	0.124	CbGbCtD
Dactinomycin—ABCG2—Cisplatin—esophageal cancer	0.0621	0.106	CbGbCtD
Dactinomycin—ABCC1—Methotrexate—esophageal cancer	0.0603	0.103	CbGbCtD
Dactinomycin—ABCG2—Methotrexate—esophageal cancer	0.0403	0.0687	CbGbCtD
Dactinomycin—ABCB1—Cisplatin—esophageal cancer	0.0224	0.0382	CbGbCtD
Dactinomycin—ABCB1—Methotrexate—esophageal cancer	0.0145	0.0248	CbGbCtD
Dactinomycin—Radiation recall reaction (dermatologic)—Capecitabine—esophageal cancer	0.00458	0.0536	CcSEcCtD
Dactinomycin—Neutropenic sepsis—Capecitabine—esophageal cancer	0.00433	0.0507	CcSEcCtD
Dactinomycin—Recall phenomenon—Capecitabine—esophageal cancer	0.00433	0.0507	CcSEcCtD
Dactinomycin—Extravasation—Carboplatin—esophageal cancer	0.00398	0.0466	CcSEcCtD
Dactinomycin—Phlebitis—Carboplatin—esophageal cancer	0.00293	0.0343	CcSEcCtD
Dactinomycin—Myelosuppression—Cisplatin—esophageal cancer	0.00217	0.0254	CcSEcCtD
Dactinomycin—Febrile neutropenia—Cisplatin—esophageal cancer	0.00169	0.0198	CcSEcCtD
Dactinomycin—Ascites—Capecitabine—esophageal cancer	0.00165	0.0194	CcSEcCtD
Dactinomycin—Hepatotoxicity—Cisplatin—esophageal cancer	0.00132	0.0155	CcSEcCtD
Dactinomycin—Necrosis—Cisplatin—esophageal cancer	0.0013	0.0152	CcSEcCtD
Dactinomycin—Febrile neutropenia—Capecitabine—esophageal cancer	0.00125	0.0146	CcSEcCtD
Dactinomycin—Infection—Carboplatin—esophageal cancer	0.00123	0.0144	CcSEcCtD
Dactinomycin—Raised liver function tests—Methotrexate—esophageal cancer	0.00121	0.0142	CcSEcCtD
Dactinomycin—Ulcerative stomatitis—Methotrexate—esophageal cancer	0.00121	0.0142	CcSEcCtD
Dactinomycin—Extravasation—Cisplatin—esophageal cancer	0.00117	0.0137	CcSEcCtD
Dactinomycin—Ulcer—Cisplatin—esophageal cancer	0.00108	0.0126	CcSEcCtD
Dactinomycin—Hepatomegaly—Capecitabine—esophageal cancer	0.00106	0.0124	CcSEcCtD
Dactinomycin—Pain—Carboplatin—esophageal cancer	0.00106	0.0124	CcSEcCtD
Dactinomycin—Body temperature increased—Carboplatin—esophageal cancer	0.00098	0.0115	CcSEcCtD
Dactinomycin—Hepatotoxicity—Capecitabine—esophageal cancer	0.000973	0.0114	CcSEcCtD
Dactinomycin—Coagulopathy—Capecitabine—esophageal cancer	0.000965	0.0113	CcSEcCtD
Dactinomycin—Febrile neutropenia—Methotrexate—esophageal cancer	0.000929	0.0109	CcSEcCtD
Dactinomycin—Eruption—Methotrexate—esophageal cancer	0.000909	0.0106	CcSEcCtD
Dactinomycin—Folliculitis—Methotrexate—esophageal cancer	0.00089	0.0104	CcSEcCtD
Dactinomycin—Phlebitis—Cisplatin—esophageal cancer	0.000859	0.0101	CcSEcCtD
Dactinomycin—Hypocalcaemia—Capecitabine—esophageal cancer	0.00082	0.00961	CcSEcCtD
Dactinomycin—Ulcer—Capecitabine—esophageal cancer	0.000794	0.0093	CcSEcCtD
Dactinomycin—Hepatotoxicity—Methotrexate—esophageal cancer	0.000724	0.00848	CcSEcCtD
Dactinomycin—Necrosis—Methotrexate—esophageal cancer	0.000712	0.00834	CcSEcCtD
Dactinomycin—Oesophagitis—Capecitabine—esophageal cancer	0.000686	0.00804	CcSEcCtD
Dactinomycin—Mouth ulceration—Capecitabine—esophageal cancer	0.000679	0.00795	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000666	0.0078	CcSEcCtD
Dactinomycin—Sepsis—Capecitabine—esophageal cancer	0.000652	0.00763	CcSEcCtD
Dactinomycin—Extravasation—Methotrexate—esophageal cancer	0.000641	0.00751	CcSEcCtD
Dactinomycin—Phlebitis—Capecitabine—esophageal cancer	0.000633	0.00741	CcSEcCtD
Dactinomycin—Pancytopenia—Cisplatin—esophageal cancer	0.000607	0.00711	CcSEcCtD
Dactinomycin—Hepatic failure—Capecitabine—esophageal cancer	0.000607	0.00711	CcSEcCtD
Dactinomycin—Ulcer—Methotrexate—esophageal cancer	0.000591	0.00692	CcSEcCtD
Dactinomycin—Lethargy—Capecitabine—esophageal cancer	0.000556	0.00652	CcSEcCtD
Dactinomycin—Stomatitis—Cisplatin—esophageal cancer	0.000556	0.00651	CcSEcCtD
Dactinomycin—Aplastic anaemia—Methotrexate—esophageal cancer	0.000525	0.00615	CcSEcCtD
Dactinomycin—Mouth ulceration—Methotrexate—esophageal cancer	0.000506	0.00592	CcSEcCtD
Dactinomycin—Liver function test abnormal—Capecitabine—esophageal cancer	0.000503	0.0059	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000491	0.00575	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000491	0.00575	CcSEcCtD
Dactinomycin—Sepsis—Methotrexate—esophageal cancer	0.000485	0.00568	CcSEcCtD
Dactinomycin—Flushing—Cisplatin—esophageal cancer	0.000475	0.00556	CcSEcCtD
Dactinomycin—Dysphagia—Capecitabine—esophageal cancer	0.000471	0.00552	CcSEcCtD
Dactinomycin—Alopecia—Cisplatin—esophageal cancer	0.000452	0.0053	CcSEcCtD
Dactinomycin—Hepatic failure—Methotrexate—esophageal cancer	0.000452	0.00529	CcSEcCtD
Dactinomycin—Pancytopenia—Capecitabine—esophageal cancer	0.000447	0.00524	CcSEcCtD
Dactinomycin—Erythema—Cisplatin—esophageal cancer	0.000445	0.00522	CcSEcCtD
Dactinomycin—Neutropenia—Capecitabine—esophageal cancer	0.000441	0.00516	CcSEcCtD
Dactinomycin—Pneumonia—Capecitabine—esophageal cancer	0.000423	0.00495	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000417	0.00488	CcSEcCtD
Dactinomycin—Lethargy—Methotrexate—esophageal cancer	0.000414	0.00485	CcSEcCtD
Dactinomycin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000413	0.00484	CcSEcCtD
Dactinomycin—Anaemia—Cisplatin—esophageal cancer	0.000412	0.00482	CcSEcCtD
Dactinomycin—Stomatitis—Capecitabine—esophageal cancer	0.00041	0.0048	CcSEcCtD
Dactinomycin—Malaise—Cisplatin—esophageal cancer	0.000402	0.0047	CcSEcCtD
Dactinomycin—Leukopenia—Cisplatin—esophageal cancer	0.000399	0.00467	CcSEcCtD
Dactinomycin—Agranulocytosis—Capecitabine—esophageal cancer	0.000392	0.00459	CcSEcCtD
Dactinomycin—Myalgia—Cisplatin—esophageal cancer	0.000379	0.00444	CcSEcCtD
Dactinomycin—Hepatitis—Capecitabine—esophageal cancer	0.000377	0.00442	CcSEcCtD
Dactinomycin—Liver function test abnormal—Methotrexate—esophageal cancer	0.000375	0.00439	CcSEcCtD
Dactinomycin—Discomfort—Cisplatin—esophageal cancer	0.000375	0.00439	CcSEcCtD
Dactinomycin—Pharyngitis—Capecitabine—esophageal cancer	0.000374	0.00438	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000365	0.00428	CcSEcCtD
Dactinomycin—Oedema—Cisplatin—esophageal cancer	0.000364	0.00426	CcSEcCtD
Dactinomycin—Infection—Cisplatin—esophageal cancer	0.000361	0.00423	CcSEcCtD
Dactinomycin—Erythema multiforme—Capecitabine—esophageal cancer	0.000357	0.00418	CcSEcCtD
Dactinomycin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000356	0.00417	CcSEcCtD
Dactinomycin—Flushing—Capecitabine—esophageal cancer	0.00035	0.0041	CcSEcCtD
Dactinomycin—Anorexia—Cisplatin—esophageal cancer	0.000347	0.00406	CcSEcCtD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000339	0.00949	CbGpPWpGaD
Dactinomycin—Chills—Capecitabine—esophageal cancer	0.000338	0.00396	CcSEcCtD
Dactinomycin—Alopecia—Capecitabine—esophageal cancer	0.000333	0.0039	CcSEcCtD
Dactinomycin—Pancytopenia—Methotrexate—esophageal cancer	0.000333	0.0039	CcSEcCtD
Dactinomycin—ABCC1—ABC-family proteins mediated transport—ABCB1—esophageal cancer	0.000332	0.00929	CbGpPWpGaD
Dactinomycin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000331	0.00388	CcSEcCtD
Dactinomycin—Erythema—Capecitabine—esophageal cancer	0.000328	0.00385	CcSEcCtD
Dactinomycin—Neutropenia—Methotrexate—esophageal cancer	0.000328	0.00384	CcSEcCtD
Dactinomycin—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000327	0.00915	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000325	0.0091	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000325	0.0091	CbGpPWpGaD
Dactinomycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—esophageal cancer	0.000322	0.00901	CbGpPWpGaD
Dactinomycin—Decreased appetite—Cisplatin—esophageal cancer	0.000316	0.0037	CcSEcCtD
Dactinomycin—Pneumonia—Methotrexate—esophageal cancer	0.000315	0.00368	CcSEcCtD
Dactinomycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000312	0.00872	CbGpPWpGaD
Dactinomycin—Pain—Cisplatin—esophageal cancer	0.000311	0.00364	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00031	0.00363	CcSEcCtD
Dactinomycin—ABCC1—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.00031	0.00867	CbGpPWpGaD
Dactinomycin—Stomatitis—Methotrexate—esophageal cancer	0.000305	0.00357	CcSEcCtD
Dactinomycin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000305	0.00357	CcSEcCtD
Dactinomycin—Anaemia—Capecitabine—esophageal cancer	0.000303	0.00355	CcSEcCtD
Dactinomycin—ABCC1—S1P1 pathway—PTGS2—esophageal cancer	0.000303	0.00848	CbGpPWpGaD
Dactinomycin—Feeling abnormal—Cisplatin—esophageal cancer	0.0003	0.00351	CcSEcCtD
Dactinomycin—ABCB1—ABC-family proteins mediated transport—ABCC2—esophageal cancer	0.000298	0.00833	CbGpPWpGaD
Dactinomycin—Malaise—Capecitabine—esophageal cancer	0.000296	0.00347	CcSEcCtD
Dactinomycin—Leukopenia—Capecitabine—esophageal cancer	0.000294	0.00344	CcSEcCtD
Dactinomycin—Agranulocytosis—Methotrexate—esophageal cancer	0.000292	0.00342	CcSEcCtD
Dactinomycin—Body temperature increased—Cisplatin—esophageal cancer	0.000287	0.00337	CcSEcCtD
Dactinomycin—Hepatitis—Methotrexate—esophageal cancer	0.000281	0.00329	CcSEcCtD
Dactinomycin—Myalgia—Capecitabine—esophageal cancer	0.00028	0.00327	CcSEcCtD
Dactinomycin—Pharyngitis—Methotrexate—esophageal cancer	0.000279	0.00326	CcSEcCtD
Dactinomycin—Discomfort—Capecitabine—esophageal cancer	0.000276	0.00323	CcSEcCtD
Dactinomycin—Oedema—Capecitabine—esophageal cancer	0.000268	0.00314	CcSEcCtD
Dactinomycin—Hypersensitivity—Cisplatin—esophageal cancer	0.000268	0.00314	CcSEcCtD
Dactinomycin—Infection—Capecitabine—esophageal cancer	0.000266	0.00312	CcSEcCtD
Dactinomycin—Erythema multiforme—Methotrexate—esophageal cancer	0.000265	0.00311	CcSEcCtD
Dactinomycin—ABCG2—Iron uptake and transport—HMOX1—esophageal cancer	0.000264	0.00739	CbGpPWpGaD
Dactinomycin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000262	0.00307	CcSEcCtD
Dactinomycin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000262	0.00732	CbGpPWpGaD
Dactinomycin—Asthenia—Cisplatin—esophageal cancer	0.000261	0.00305	CcSEcCtD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—ENO1—esophageal cancer	0.000257	0.00719	CbGpPWpGaD
Dactinomycin—SLC22A5—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000257	0.00719	CbGpPWpGaD
Dactinomycin—Anorexia—Capecitabine—esophageal cancer	0.000255	0.00299	CcSEcCtD
Dactinomycin—Chills—Methotrexate—esophageal cancer	0.000252	0.00295	CcSEcCtD
Dactinomycin—Diarrhoea—Cisplatin—esophageal cancer	0.000249	0.00291	CcSEcCtD
Dactinomycin—Alopecia—Methotrexate—esophageal cancer	0.000248	0.00291	CcSEcCtD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000247	0.0069	CbGpPWpGaD
Dactinomycin—Erythema—Methotrexate—esophageal cancer	0.000244	0.00286	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000244	0.00286	CcSEcCtD
Dactinomycin—ABCG2—HIF-2-alpha transcription factor network—KDR—esophageal cancer	0.000239	0.0067	CbGpPWpGaD
Dactinomycin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—esophageal cancer	0.000236	0.0066	CbGpPWpGaD
Dactinomycin—SLC22A5—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000235	0.00657	CbGpPWpGaD
Dactinomycin—Decreased appetite—Capecitabine—esophageal cancer	0.000233	0.00273	CcSEcCtD
Dactinomycin—Vomiting—Cisplatin—esophageal cancer	0.000231	0.00271	CcSEcCtD
Dactinomycin—Fatigue—Capecitabine—esophageal cancer	0.000231	0.00271	CcSEcCtD
Dactinomycin—Rash—Cisplatin—esophageal cancer	0.000229	0.00268	CcSEcCtD
Dactinomycin—Pain—Capecitabine—esophageal cancer	0.000229	0.00268	CcSEcCtD
Dactinomycin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—esophageal cancer	0.000228	0.00639	CbGpPWpGaD
Dactinomycin—Ill-defined disorder—Methotrexate—esophageal cancer	0.000227	0.00266	CcSEcCtD
Dactinomycin—Anaemia—Methotrexate—esophageal cancer	0.000226	0.00265	CcSEcCtD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000224	0.00626	CbGpPWpGaD
Dactinomycin—Feeling abnormal—Capecitabine—esophageal cancer	0.000221	0.00259	CcSEcCtD
Dactinomycin—Malaise—Methotrexate—esophageal cancer	0.00022	0.00258	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000219	0.00257	CcSEcCtD
Dactinomycin—Leukopenia—Methotrexate—esophageal cancer	0.000219	0.00256	CcSEcCtD
Dactinomycin—Nausea—Cisplatin—esophageal cancer	0.000216	0.00253	CcSEcCtD
Dactinomycin—Abdominal pain—Capecitabine—esophageal cancer	0.000212	0.00248	CcSEcCtD
Dactinomycin—Body temperature increased—Capecitabine—esophageal cancer	0.000212	0.00248	CcSEcCtD
Dactinomycin—Myalgia—Methotrexate—esophageal cancer	0.000208	0.00244	CcSEcCtD
Dactinomycin—Discomfort—Methotrexate—esophageal cancer	0.000206	0.00241	CcSEcCtD
Dactinomycin—ABCG2—HIF-2-alpha transcription factor network—CREBBP—esophageal cancer	0.000204	0.00572	CbGpPWpGaD
Dactinomycin—Infection—Methotrexate—esophageal cancer	0.000198	0.00232	CcSEcCtD
Dactinomycin—Hypersensitivity—Capecitabine—esophageal cancer	0.000197	0.00231	CcSEcCtD
Dactinomycin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000195	0.00229	CcSEcCtD
Dactinomycin—Asthenia—Capecitabine—esophageal cancer	0.000192	0.00225	CcSEcCtD
Dactinomycin—Anorexia—Methotrexate—esophageal cancer	0.00019	0.00223	CcSEcCtD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—HMOX1—esophageal cancer	0.000187	0.00524	CbGpPWpGaD
Dactinomycin—Diarrhoea—Capecitabine—esophageal cancer	0.000183	0.00215	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000182	0.00213	CcSEcCtD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—SMAD4—esophageal cancer	0.00018	0.00503	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—ABCB1—esophageal cancer	0.00018	0.00503	CbGpPWpGaD
Dactinomycin—Decreased appetite—Methotrexate—esophageal cancer	0.000173	0.00203	CcSEcCtD
Dactinomycin—Fatigue—Methotrexate—esophageal cancer	0.000172	0.00201	CcSEcCtD
Dactinomycin—Pain—Methotrexate—esophageal cancer	0.000171	0.002	CcSEcCtD
Dactinomycin—Vomiting—Capecitabine—esophageal cancer	0.00017	0.002	CcSEcCtD
Dactinomycin—Rash—Capecitabine—esophageal cancer	0.000169	0.00198	CcSEcCtD
Dactinomycin—Feeling abnormal—Methotrexate—esophageal cancer	0.000164	0.00193	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000163	0.00191	CcSEcCtD
Dactinomycin—Nausea—Capecitabine—esophageal cancer	0.000159	0.00186	CcSEcCtD
Dactinomycin—Body temperature increased—Methotrexate—esophageal cancer	0.000158	0.00185	CcSEcCtD
Dactinomycin—Abdominal pain—Methotrexate—esophageal cancer	0.000158	0.00185	CcSEcCtD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	0.000147	0.00412	CbGpPWpGaD
Dactinomycin—Hypersensitivity—Methotrexate—esophageal cancer	0.000147	0.00172	CcSEcCtD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000146	0.0041	CbGpPWpGaD
Dactinomycin—Asthenia—Methotrexate—esophageal cancer	0.000143	0.00168	CcSEcCtD
Dactinomycin—ABCC1—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.00014	0.00391	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-2-alpha transcription factor network—EP300—esophageal cancer	0.000139	0.0039	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—ENO1—esophageal cancer	0.000139	0.00389	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000138	0.00385	CbGpPWpGaD
Dactinomycin—Diarrhoea—Methotrexate—esophageal cancer	0.000136	0.0016	CcSEcCtD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000136	0.00381	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	0.000134	0.00375	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000131	0.00366	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000131	0.00365	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—esophageal cancer	0.000127	0.00357	CbGpPWpGaD
Dactinomycin—Vomiting—Methotrexate—esophageal cancer	0.000127	0.00149	CcSEcCtD
Dactinomycin—Rash—Methotrexate—esophageal cancer	0.000126	0.00147	CcSEcCtD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000125	0.00348	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	0.00012	0.00336	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000119	0.00334	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000119	0.00334	CbGpPWpGaD
Dactinomycin—Nausea—Methotrexate—esophageal cancer	0.000118	0.00139	CcSEcCtD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000111	0.00311	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.00011	0.00309	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000106	0.00296	CbGpPWpGaD
Dactinomycin—ABCG2—Fluoropyrimidine Activity—TP53—esophageal cancer	0.000102	0.00285	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—esophageal cancer	0.000101	0.00284	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	9.95e-05	0.00278	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—SMAD4—esophageal cancer	9.73e-05	0.00272	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	9.43e-05	0.00264	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	9.31e-05	0.00261	CbGpPWpGaD
Dactinomycin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	9.06e-05	0.00253	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—ABCC2—esophageal cancer	9.05e-05	0.00253	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—AQP3—esophageal cancer	9e-05	0.00252	CbGpPWpGaD
Dactinomycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—esophageal cancer	8.97e-05	0.00251	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	8.76e-05	0.00245	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.74e-05	0.00245	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	8.63e-05	0.00241	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	8.63e-05	0.00241	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	8.57e-05	0.0024	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	8.3e-05	0.00232	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—GNG7—esophageal cancer	8.21e-05	0.0023	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—EP300—esophageal cancer	8.19e-05	0.00229	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	7.96e-05	0.00223	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—AQP3—esophageal cancer	7.92e-05	0.00222	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	7.59e-05	0.00212	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	7.59e-05	0.00212	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	7.52e-05	0.0021	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	7.24e-05	0.00203	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—SLC52A3—esophageal cancer	6.96e-05	0.00195	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—KMT2D—esophageal cancer	6.64e-05	0.00186	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	6.56e-05	0.00184	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.54e-05	0.00183	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	6.5e-05	0.00182	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.93e-05	0.00166	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—BLVRB—esophageal cancer	5.83e-05	0.00163	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—SLC52A3—esophageal cancer	5.83e-05	0.00163	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	5.82e-05	0.00163	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	5.75e-05	0.00161	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—CASP8—esophageal cancer	5.66e-05	0.00158	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	5.33e-05	0.00149	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.22e-05	0.00146	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	5.21e-05	0.00146	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—FKBP1A—esophageal cancer	5.15e-05	0.00144	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—SLC52A3—esophageal cancer	5.13e-05	0.00144	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—BLVRB—esophageal cancer	5.13e-05	0.00144	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	5.07e-05	0.00142	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	5.04e-05	0.00141	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—DOCK2—esophageal cancer	5.03e-05	0.00141	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—WIF1—esophageal cancer	5.03e-05	0.00141	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5e-05	0.0014	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CA1—esophageal cancer	4.96e-05	0.00139	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—SLC10A2—esophageal cancer	4.96e-05	0.00139	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	4.9e-05	0.00137	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.8e-05	0.00134	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	4.73e-05	0.00132	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CSNK1A1—esophageal cancer	4.64e-05	0.0013	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CA2—esophageal cancer	4.53e-05	0.00127	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	4.49e-05	0.00126	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.43e-05	0.00124	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	4.43e-05	0.00124	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—SLC10A2—esophageal cancer	4.36e-05	0.00122	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CA1—esophageal cancer	4.36e-05	0.00122	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	4.29e-05	0.0012	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	4.28e-05	0.0012	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PLCE1—esophageal cancer	4.21e-05	0.00118	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ADH7—esophageal cancer	4.21e-05	0.00118	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.17e-05	0.00117	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	4.16e-05	0.00116	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	4.1e-05	0.00115	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	4.1e-05	0.00115	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CA2—esophageal cancer	3.99e-05	0.00112	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	3.93e-05	0.0011	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ELMO1—esophageal cancer	3.9e-05	0.00109	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—GSTO1—esophageal cancer	3.81e-05	0.00107	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—TPI1—esophageal cancer	3.81e-05	0.00107	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PLCE1—esophageal cancer	3.71e-05	0.00104	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ADH7—esophageal cancer	3.71e-05	0.00104	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ADH1B—esophageal cancer	3.7e-05	0.00103	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ALDOB—esophageal cancer	3.66e-05	0.00102	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.61e-05	0.00101	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—TYMP—esophageal cancer	3.53e-05	0.000988	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HIST1H2BM—esophageal cancer	3.52e-05	0.000985	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—GAPDH—esophageal cancer	3.52e-05	0.000985	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.47e-05	0.000971	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CYP26A1—esophageal cancer	3.44e-05	0.000961	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ALOX15—esophageal cancer	3.35e-05	0.000937	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ADH1B—esophageal cancer	3.25e-05	0.00091	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.21e-05	0.000898	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTO1—esophageal cancer	3.19e-05	0.000894	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—TPI1—esophageal cancer	3.19e-05	0.000894	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.18e-05	0.00089	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	3.11e-05	0.00087	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—XIAP—esophageal cancer	3.11e-05	0.00087	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—TYMP—esophageal cancer	3.11e-05	0.000869	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ALDOB—esophageal cancer	3.06e-05	0.000857	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.05e-05	0.000854	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CYP26A1—esophageal cancer	3.02e-05	0.000846	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GAPDH—esophageal cancer	2.95e-05	0.000825	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ALOX15—esophageal cancer	2.95e-05	0.000824	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CRABP1—esophageal cancer	2.92e-05	0.000817	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—B2M—esophageal cancer	2.89e-05	0.000809	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	2.82e-05	0.00079	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—TPI1—esophageal cancer	2.81e-05	0.000786	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTO1—esophageal cancer	2.81e-05	0.000786	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	2.79e-05	0.000781	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GNG7—esophageal cancer	2.78e-05	0.000777	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	2.78e-05	0.000777	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—SLC52A3—esophageal cancer	2.77e-05	0.000776	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—BLVRB—esophageal cancer	2.77e-05	0.000776	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ENO1—esophageal cancer	2.77e-05	0.000775	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PSME2—esophageal cancer	2.73e-05	0.000764	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PSME1—esophageal cancer	2.73e-05	0.000764	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ALDOB—esophageal cancer	2.69e-05	0.000754	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CALR—esophageal cancer	2.62e-05	0.000733	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ALDH2—esophageal cancer	2.6e-05	0.000728	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GAPDH—esophageal cancer	2.59e-05	0.000726	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CRABP1—esophageal cancer	2.57e-05	0.000719	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—FBXW7—esophageal cancer	2.53e-05	0.000709	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTT1—esophageal cancer	2.48e-05	0.000693	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CYP2A6—esophageal cancer	2.45e-05	0.000685	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GNG7—esophageal cancer	2.45e-05	0.000684	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.44e-05	0.000682	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	2.4e-05	0.00067	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CA1—esophageal cancer	2.36e-05	0.00066	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—SLC10A2—esophageal cancer	2.36e-05	0.00066	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	2.33e-05	0.000651	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PTGS1—esophageal cancer	2.32e-05	0.000649	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ENO1—esophageal cancer	2.32e-05	0.000649	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.32e-05	0.000649	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ALDH2—esophageal cancer	2.29e-05	0.000641	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PSME2—esophageal cancer	2.29e-05	0.00064	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PSME1—esophageal cancer	2.29e-05	0.00064	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	2.28e-05	0.000637	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTT1—esophageal cancer	2.18e-05	0.00061	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CA2—esophageal cancer	2.16e-05	0.000603	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CYP2A6—esophageal cancer	2.15e-05	0.000603	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	2.06e-05	0.000575	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—TGFBR2—esophageal cancer	2.05e-05	0.000573	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ENO1—esophageal cancer	2.04e-05	0.000571	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PTGS1—esophageal cancer	2.04e-05	0.000571	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.04e-05	0.000571	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PSME2—esophageal cancer	2.01e-05	0.000563	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PSME1—esophageal cancer	2.01e-05	0.000563	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PLCE1—esophageal cancer	2.01e-05	0.000561	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ADH7—esophageal cancer	2.01e-05	0.000561	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2e-05	0.000559	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.99e-05	0.000556	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CYP1B1—esophageal cancer	1.97e-05	0.000552	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—SMAD4—esophageal cancer	1.94e-05	0.000543	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.89e-05	0.000529	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CYP19A1—esophageal cancer	1.86e-05	0.000519	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ADH1B—esophageal cancer	1.76e-05	0.000492	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CYP1B1—esophageal cancer	1.74e-05	0.000486	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.72e-05	0.000481	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—HMOX1—esophageal cancer	1.69e-05	0.000474	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—TYMP—esophageal cancer	1.68e-05	0.00047	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.66e-05	0.000465	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.65e-05	0.000461	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.63e-05	0.000457	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CYP19A1—esophageal cancer	1.63e-05	0.000457	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ABCB1—esophageal cancer	1.63e-05	0.000455	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.61e-05	0.000451	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ALOX15—esophageal cancer	1.59e-05	0.000446	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HIF1A—esophageal cancer	1.59e-05	0.000444	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—TPI1—esophageal cancer	1.52e-05	0.000425	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTO1—esophageal cancer	1.52e-05	0.000425	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—HMOX1—esophageal cancer	1.49e-05	0.000417	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ALDOB—esophageal cancer	1.46e-05	0.000408	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—NOS2—esophageal cancer	1.44e-05	0.000404	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—NOTCH1—esophageal cancer	1.43e-05	0.0004	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ABCB1—esophageal cancer	1.43e-05	0.0004	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GAPDH—esophageal cancer	1.4e-05	0.000392	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.4e-05	0.000392	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CRABP1—esophageal cancer	1.39e-05	0.000389	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.35e-05	0.000379	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GNG7—esophageal cancer	1.32e-05	0.00037	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CREBBP—esophageal cancer	1.3e-05	0.000363	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ALDH2—esophageal cancer	1.24e-05	0.000347	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.23e-05	0.000344	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTT1—esophageal cancer	1.18e-05	0.00033	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.16e-05	0.000326	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—NOS3—esophageal cancer	1.16e-05	0.000325	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ENO1—esophageal cancer	1.1e-05	0.000309	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PTGS1—esophageal cancer	1.1e-05	0.000309	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.1e-05	0.000309	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PSME2—esophageal cancer	1.09e-05	0.000304	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PSME1—esophageal cancer	1.09e-05	0.000304	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CREBBP—esophageal cancer	1.09e-05	0.000304	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ERBB2—esophageal cancer	1.09e-05	0.000304	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PTGS2—esophageal cancer	1.06e-05	0.000297	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—NOS3—esophageal cancer	9.72e-06	0.000272	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CREBBP—esophageal cancer	9.56e-06	0.000267	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CYP1B1—esophageal cancer	9.39e-06	0.000263	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CDKN1A—esophageal cancer	9.28e-06	0.00026	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PTGS2—esophageal cancer	8.89e-06	0.000249	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—EP300—esophageal cancer	8.83e-06	0.000247	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CYP19A1—esophageal cancer	8.83e-06	0.000247	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—NOS3—esophageal cancer	8.56e-06	0.000239	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—HMOX1—esophageal cancer	8.05e-06	0.000225	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PTGS2—esophageal cancer	7.83e-06	0.000219	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MYC—esophageal cancer	7.7e-06	0.000215	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—EGFR—esophageal cancer	7.53e-06	0.000211	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—EP300—esophageal cancer	7.4e-06	0.000207	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PIK3CA—esophageal cancer	6.53e-06	0.000183	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—EP300—esophageal cancer	6.51e-06	0.000182	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIK3CA—esophageal cancer	5.47e-06	0.000153	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CREBBP—esophageal cancer	5.17e-06	0.000145	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIK3CA—esophageal cancer	4.81e-06	0.000135	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—NOS3—esophageal cancer	4.63e-06	0.000129	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PTGS2—esophageal cancer	4.23e-06	0.000118	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—EP300—esophageal cancer	3.52e-06	9.85e-05	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.6e-06	7.28e-05	CbGpPWpGaD
